Cargando…

Design and development of hydrogel nanoparticles for mercaptopurine

Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegr...

Descripción completa

Detalles Bibliográficos
Autores principales: Senthil, V., Kumar, R. Suresh, Nagaraju, C. V. V., Jawahar, N., Ganesh, G. N. K., Gowthamarajan, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255408/
https://www.ncbi.nlm.nih.gov/pubmed/22247867
http://dx.doi.org/10.4103/0110-5558.72431
_version_ 1782220995534258176
author Senthil, V.
Kumar, R. Suresh
Nagaraju, C. V. V.
Jawahar, N.
Ganesh, G. N. K.
Gowthamarajan, K.
author_facet Senthil, V.
Kumar, R. Suresh
Nagaraju, C. V. V.
Jawahar, N.
Ganesh, G. N. K.
Gowthamarajan, K.
author_sort Senthil, V.
collection PubMed
description Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegradable, and biocompatible polymers like chitosan and carrageenan. As these polymers are hydrophilic in nature, the particles will have a long life span in systemic circulation. Hydrogel nanoparticles with mercaptopurine is form an antileukemia drug by the counter polymer gelation method. Fourier-Transform Infrared (FT-IR) studies have shown a compatibility of polymers with the drug. The diameter of hydrogel nanoparticles was about 370 – 800 nm with a positive zeta potential of 26 – 30 mV. The hydrogel nanoparticles were almost spherical in shape, as revealed by scanning electron microscopy (SEM). Drug loading varied from 9 to 17%. Mercaptopurine released from the nanoparticles at the end of the twenty-fourth hour was about 69.48 – 76.52% at pH 7.4. The drug release from the formulation was following zero order kinetics, which was evident from the release kinetic studies and the mechanism of drug release was anomalous diffusion, which indicated that the drug release was controlled by more than one process.
format Online
Article
Text
id pubmed-3255408
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32554082012-01-13 Design and development of hydrogel nanoparticles for mercaptopurine Senthil, V. Kumar, R. Suresh Nagaraju, C. V. V. Jawahar, N. Ganesh, G. N. K. Gowthamarajan, K. J Adv Pharm Technol Res Original Article Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegradable, and biocompatible polymers like chitosan and carrageenan. As these polymers are hydrophilic in nature, the particles will have a long life span in systemic circulation. Hydrogel nanoparticles with mercaptopurine is form an antileukemia drug by the counter polymer gelation method. Fourier-Transform Infrared (FT-IR) studies have shown a compatibility of polymers with the drug. The diameter of hydrogel nanoparticles was about 370 – 800 nm with a positive zeta potential of 26 – 30 mV. The hydrogel nanoparticles were almost spherical in shape, as revealed by scanning electron microscopy (SEM). Drug loading varied from 9 to 17%. Mercaptopurine released from the nanoparticles at the end of the twenty-fourth hour was about 69.48 – 76.52% at pH 7.4. The drug release from the formulation was following zero order kinetics, which was evident from the release kinetic studies and the mechanism of drug release was anomalous diffusion, which indicated that the drug release was controlled by more than one process. Medknow Publications & Media Pvt Ltd 2010 /pmc/articles/PMC3255408/ /pubmed/22247867 http://dx.doi.org/10.4103/0110-5558.72431 Text en Copyright: © Journal of Advanced Pharmaceutical Technology & Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Senthil, V.
Kumar, R. Suresh
Nagaraju, C. V. V.
Jawahar, N.
Ganesh, G. N. K.
Gowthamarajan, K.
Design and development of hydrogel nanoparticles for mercaptopurine
title Design and development of hydrogel nanoparticles for mercaptopurine
title_full Design and development of hydrogel nanoparticles for mercaptopurine
title_fullStr Design and development of hydrogel nanoparticles for mercaptopurine
title_full_unstemmed Design and development of hydrogel nanoparticles for mercaptopurine
title_short Design and development of hydrogel nanoparticles for mercaptopurine
title_sort design and development of hydrogel nanoparticles for mercaptopurine
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255408/
https://www.ncbi.nlm.nih.gov/pubmed/22247867
http://dx.doi.org/10.4103/0110-5558.72431
work_keys_str_mv AT senthilv designanddevelopmentofhydrogelnanoparticlesformercaptopurine
AT kumarrsuresh designanddevelopmentofhydrogelnanoparticlesformercaptopurine
AT nagarajucvv designanddevelopmentofhydrogelnanoparticlesformercaptopurine
AT jawaharn designanddevelopmentofhydrogelnanoparticlesformercaptopurine
AT ganeshgnk designanddevelopmentofhydrogelnanoparticlesformercaptopurine
AT gowthamarajank designanddevelopmentofhydrogelnanoparticlesformercaptopurine